Ad is loading...
HGHTX vs VHCIX
HGHTX vs VHCIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
HGHTX vs. VHCIX commentary
Dec 19, 2024
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HGHTX is a Buy and VHCIX is a Buy.
FUNDAMENTALS
Fundamentals
VHCIX has more cash in the bank: 20.6B vs. HGHTX (952M). VHCIX pays higher dividends than HGHTX: VHCIX (1.28) vs HGHTX (0.00). HGHTX was incepted earlier than VHCIX: HGHTX (18 years) vs VHCIX (21 years). HGHTX is a more actively managed with annual turnover of: 32.00 vs. VHCIX (4.00). HGHTX has a lower initial minimum investment than VHCIX: HGHTX (0) vs VHCIX (100000). VHCIX annual gain was more profitable for investors over the last year : 5.56 vs. HGHTX (0.46). VHCIX return over 5 years is better than : 35.76 vs. HGHTX (0.37).
| HGHTX | VHCIX | HGHTX / VHCIX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 18 years | 21 years | - |
| Gain YTD | -1.989 | 3.274 | -61% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 100000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 952M | 20.6B | 5% |
| Annual Yield % from dividends | 0.00 | 1.28 | - |
| Returns for 1 year | 0.46 | 5.56 | 8% |
| Returns for 3 years | -8.50 | -0.62 | 1,379% |
| Returns for 5 years | 0.37 | 35.76 | 1% |
| Returns for 10 years | 9.11 | 100.66 | 9% |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EDV | 71.85 | 0.51 | +0.71% |
| Vanguard Extended Duration Trs ETF | |||
| TPYP | 34.16 | -0.20 | -0.58% |
| Tortoise North American Pipeline | |||
| FJP | 51.06 | -0.35 | -0.68% |
| First Trust Japan AlphaDEX® ETF | |||
| FDCF | 39.10 | -0.30 | -0.77% |
| Fidelity Disruptive Communications ETF | |||
| CNCR | 12.66 | -0.15 | -1.20% |
| Range Cancer Therapeutics ETF | |||